STERIS plc (NYSE:STE) Shares Sold by Rockefeller Capital Management L.P.

Rockefeller Capital Management L.P. decreased its position in STERIS plc (NYSE:STE) by 1.9% in the 3rd quarter, Holdings Channel reports. The fund owned 95,062 shares of the medical equipment provider’s stock after selling 1,796 shares during the period. Rockefeller Capital Management L.P.’s holdings in STERIS were worth $23,055,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in STE. West Coast Financial LLC grew its holdings in STERIS by 2.8% during the 3rd quarter. West Coast Financial LLC now owns 1,640 shares of the medical equipment provider’s stock valued at $398,000 after purchasing an additional 45 shares in the last quarter. Taylor Frigon Capital Management LLC grew its stake in shares of STERIS by 0.8% during the second quarter. Taylor Frigon Capital Management LLC now owns 6,175 shares of the medical equipment provider’s stock valued at $1,356,000 after acquiring an additional 46 shares in the last quarter. Mather Group LLC. grew its stake in shares of STERIS by 7.6% during the second quarter. Mather Group LLC. now owns 763 shares of the medical equipment provider’s stock valued at $172,000 after acquiring an additional 54 shares in the last quarter. EverSource Wealth Advisors LLC increased its position in shares of STERIS by 16.5% during the first quarter. EverSource Wealth Advisors LLC now owns 402 shares of the medical equipment provider’s stock worth $82,000 after acquiring an additional 57 shares during the last quarter. Finally, Waterloo Capital L.P. lifted its stake in shares of STERIS by 3.2% in the second quarter. Waterloo Capital L.P. now owns 1,916 shares of the medical equipment provider’s stock worth $421,000 after acquiring an additional 59 shares in the last quarter. Hedge funds and other institutional investors own 94.69% of the company’s stock.

Insiders Place Their Bets

In other news, SVP Cary L. Majors sold 1,682 shares of the business’s stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $217.32, for a total transaction of $365,532.24. Following the completion of the transaction, the senior vice president now directly owns 11,372 shares in the company, valued at approximately $2,471,363.04. The trade was a 12.88 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Michael J. Tokich sold 23,332 shares of the firm’s stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $247.00, for a total value of $5,763,004.00. Following the completion of the sale, the chief financial officer now owns 42,930 shares in the company, valued at approximately $10,603,710. This represents a 35.21 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several equities research analysts have issued reports on the company. Stephens restated an “overweight” rating and set a $260.00 price objective on shares of STERIS in a report on Thursday, November 7th. KeyCorp upped their price target on shares of STERIS from $255.00 to $265.00 and gave the company an “overweight” rating in a report on Tuesday, September 3rd. Piper Sandler upgraded shares of STERIS from a “neutral” rating to an “overweight” rating and increased their price objective for the company from $230.00 to $260.00 in a research note on Thursday, October 24th. Needham & Company LLC reissued a “hold” rating on shares of STERIS in a research report on Friday, November 8th. Finally, StockNews.com cut shares of STERIS from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, October 29th. Two analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $253.00.

STERIS Stock Up 0.7 %

Shares of NYSE:STE opened at $219.06 on Friday. The company’s fifty day moving average is $225.01 and its two-hundred day moving average is $228.28. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.55 and a current ratio of 2.41. STERIS plc has a 1-year low of $195.47 and a 1-year high of $248.24. The stock has a market capitalization of $21.62 billion, a price-to-earnings ratio of 50.01 and a beta of 0.85.

STERIS (NYSE:STE) last issued its earnings results on Wednesday, November 6th. The medical equipment provider reported $2.14 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.12 by $0.02. The firm had revenue of $1.33 billion for the quarter, compared to analysts’ expectations of $1.33 billion. STERIS had a net margin of 8.02% and a return on equity of 13.78%. STERIS’s revenue was up 7.3% on a year-over-year basis. During the same quarter last year, the company posted $2.03 earnings per share. Equities analysts anticipate that STERIS plc will post 9.15 EPS for the current year.

STERIS Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 19th. Investors of record on Tuesday, November 19th will be paid a dividend of $0.57 per share. The ex-dividend date of this dividend is Tuesday, November 19th. This represents a $2.28 dividend on an annualized basis and a yield of 1.04%. STERIS’s payout ratio is currently 52.05%.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.